{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:31:46Z","timestamp":1791829906521,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972919"],"award-info":[{"award-number":["81972919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273513"],"award-info":[{"award-number":["82273513"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mechanisms of Ageing and Development"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.mad.2023.111779","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:31:40Z","timestamp":1675045900000},"page":"111779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Acceleration of melanocyte senescence by the proinflammatory cytokines IFN\u03b3 and TNF\u03b1 impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy"],"prefix":"10.1016","volume":"211","author":[{"given":"Bing-Qi","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Kai","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Fei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Caroline","family":"Le Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Chi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mad.2023.111779_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/pcmr.12878","article-title":"The enigma and challenges of vitiligo pathophysiology and treatment","volume":"33","author":"Abdel-Malek","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.mad.2023.111779_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2017.0002","article-title":"Phototherapy for vitiligo: a systematic review and meta-analysis","volume":"153","author":"Bae","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.mad.2023.111779_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.72","article-title":"Modeling skin inflammation using human in vitro models","volume":"1","author":"Boarder","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.mad.2023.111779_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.mad.2023.111779_bib5","first-page":"1","article-title":"Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo","volume":"5","author":"Boukhedouni","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.mad.2023.111779_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/pde.13517","article-title":"Therapeutic interventions to. lessen the psychosocial effect of vitiligo in children: a review","volume":"35","author":"Cadmus","year":"2018","journal-title":"Ped Dermatol."},{"key":"10.1016\/j.mad.2023.111779_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0145-2126(00)00122-3","article-title":"Soluble Kit receptor blocks stem cell factor bioactivity in vitro","volume":"25","author":"Dahlen","year":"2001","journal-title":"Leuk. Res"},{"key":"10.1016\/j.mad.2023.111779_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/dth.12384","article-title":"The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial","volume":"29","author":"El Mofty","year":"2016","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.mad.2023.111779_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bjd.20596","article-title":"British Association of Dermatologists\u2019 Clinical Standards Unit. British Association of Dermatologists guidelines for the management of people with vitiligo 2021","volume":"186","author":"Eleftheriadou","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.mad.2023.111779_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/phpp.12749","article-title":"Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): A double-blind, randomized, placebo-controlled, prospective, multicenter study","volume":"38","author":"Esmat","year":"2022","journal-title":"Photo Photo Photo"},{"key":"10.1016\/j.mad.2023.111779_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: Mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.mad.2023.111779_bib12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/jid.2008.9","article-title":"Production of the soluble form of KIT, s-KIT, abolishes stem cell factor-induced melanogenesis in human melanocytes","volume":"128","author":"Kasamatsu","year":"2008","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.mad.2023.111779_bib13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.187.10.1565","article-title":"Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor","volume":"187","author":"Kunisada","year":"1998","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.mad.2023.111779_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11626-997-0021-6","article-title":"Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genes","volume":"33","author":"Le Poole","year":"1997","journal-title":"Vitr. Cell Dev. Biol. Anim."},{"key":"10.1016\/j.mad.2023.111779_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1290\/1071-2690(2000)036<0309:PAIHVM>2.0.CO;2","article-title":"PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum","volume":"36","author":"Le Poole","year":"2000","journal-title":"Vitr. Cell Dev. Biol. Anim."},{"key":"10.1016\/j.mad.2023.111779_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000439563","article-title":"A retrospective study of methylprednisolone mini-pulse therapy combined with narrow-band UVB in non-segmental vitiligo","volume":"232","author":"Lee","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.mad.2023.111779_bib17","first-page":"878","article-title":"P16IN4KA positivity of melanocytes in non-segmental vitiligo","volume":"10","author":"Lee","year":"2020","journal-title":"Diagn. (Basel)"},{"key":"10.1016\/j.mad.2023.111779_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JD9.0000000000000151","article-title":"Consensus on the diagnosis and treatment of vitiligo in China (2021 Revision)","volume":"4","author":"Lei","year":"2021","journal-title":"Int J. Dermatol. Venereol."},{"key":"10.1016\/j.mad.2023.111779_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1471-4906(01)01941-X","article-title":"Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines","volume":"22","author":"Mantovani","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.mad.2023.111779_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3892\/ijmm.2017.3019","article-title":"Lentiviral vector-mediated co-overexpression of VEGF and Bcl-2 improves mesenchymal stem cell survival and enhances paracrine effects in vitro","volume":"40","author":"Ni","year":"2017","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.mad.2023.111779_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.mad.2023.111779_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40257-016-0172-x","article-title":"Social anxiety and quality of life in vitiligo and acne patients with facial involvement: a cross-sectional controlled study","volume":"17","author":"Salman","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.mad.2023.111779_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","article-title":"Biomarkers of disease activity in vitiligo: a systematic review","volume":"16","author":"Speeckaert","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.mad.2023.111779_bib24","first-page":"1017","article-title":"Role of the P53\u2013TRPM1\/miR\u2011211\u2013MMP9 axis in UVB\u2011induced human melanocyte migration and its potential in repigmentation","volume":"45","author":"Su","year":"2020","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.mad.2023.111779_bib25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/pcmr.12974","article-title":"Vitiligo: Translational research and effective therapeutic strategies","volume":"34","author":"Thakur","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.mad.2023.111779_bib26","article-title":"Interferon-\u03b3 induces senescence in normal human melanocytes","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mad.2023.111779_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0022-202x.2001.00006.x","article-title":"Review: Melanocyte migration and survival controlled by SCF\/c-kit expression","volume":"6","author":"Yoshida","year":"2001","journal-title":"J. Invest Dermatol. Symp. Proc."}],"container-title":["Mechanisms of Ageing and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637423000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637423000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:48:46Z","timestamp":1758649726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0047637423000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":27,"alternative-id":["S0047637423000052"],"URL":"https:\/\/doi.org\/10.1016\/j.mad.2023.111779","relation":{},"ISSN":["0047-6374"],"issn-type":[{"value":"0047-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceleration of melanocyte senescence by the proinflammatory cytokines IFN\u03b3 and TNF\u03b1 impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy","name":"articletitle","label":"Article Title"},{"value":"Mechanisms of Ageing and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mad.2023.111779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111779"}}